← All companies

TXMD

TherapeuticsMD, Inc.

TXMD Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.04

+0.01 +0.49%

Key statistics

from XBRL data in SEC filings

Market cap

$23.6M

Revenue (TTM)

$3.35M

Net income (TTM)

$179K

EPS (TTM)

$0.02

P/E ratio

102.0

Dividend yield

—

Free cash flow

$2.42M

Cash

$8.42M

Total assets

$37.6M

Gross margin

38.8%

52-week range

$0.99 – $2.95

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 1, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Changed accountants Jan 21, 2026 8-K Shareholder vote results Dec 16, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 13, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Other events Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 27, 2025 8-K Shareholder vote results Dec 5, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2024 8-K Item 5.08 Sep 20, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 10, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 29, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 14, 2023 8-K Entered a material agreement; Director or officer change Aug 18, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2023 8-K Changed accountants Jul 10, 2023 8-K Unregistered sale of equity; Amended charter or bylaws Jul 6, 2023 8-K Shareholder vote results Jun 28, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2023 8-K Entered a material agreement May 5, 2023 10-K/A Fiscal year ended 2022-12-31 May 1, 2023